Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Quanterix ( (QTRX) ) just unveiled an update.
On September 29, 2025, Quanterix Corporation held its Annual Meeting of Stockholders, where several key proposals were approved. These included the election of three independent directors, approval of executive compensation, ratification of KPMG as the accounting firm, and amendments to the company’s Charter to declassify the board and eliminate supermajority voting requirements. These changes are expected to streamline governance and potentially enhance shareholder influence in corporate decisions.
The most recent analyst rating on (QTRX) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Quanterix stock, see the QTRX Stock Forecast page.
Spark’s Take on QTRX Stock
According to Spark, TipRanks’ AI Analyst, QTRX is a Neutral.
Quanterix’s overall stock score is primarily impacted by its challenging financial performance, with declining revenues and persistent losses. Technical analysis suggests a bearish trend, and valuation metrics indicate limited immediate return potential. While the earnings call provided some positive long-term strategic insights, the current financial challenges remain significant.
To see Spark’s full report on QTRX stock, click here.
More about Quanterix
Quanterix Corporation operates in the biotechnology industry, focusing on developing ultra-sensitive digital immunoassay technology. The company’s primary products and services include advanced diagnostic tools that enable the detection of biomarkers for various diseases, with a market focus on enhancing precision health.
Average Trading Volume: 661,138
Technical Sentiment Signal: Sell
Current Market Cap: $257.4M
For detailed information about QTRX stock, go to TipRanks’ Stock Analysis page.